National Health Investors, Inc. (NYSE:NHI) Receives $73.29 Average PT from Analysts

Shares of National Health Investors, Inc. (NYSE:NHI) have earned a consensus rating of “Moderate Buy” from the seven ratings firms that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $73.29.

A number of research firms have commented on NHI. StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Bank of America began coverage on National Health Investors in a research report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price target on the stock. Truist Financial upped their price target on National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research report on Friday, August 30th. Finally, Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their price objective for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st.

National Health Investors Trading Down 0.9 %

Shares of NHI stock opened at $77.14 on Monday. The firm has a market capitalization of $3.50 billion, a P/E ratio of 26.51, a P/E/G ratio of 5.19 and a beta of 1.05. National Health Investors has a twelve month low of $51.59 and a twelve month high of $86.13. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The stock’s fifty day simple moving average is $79.74 and its 200 day simple moving average is $74.25.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The company had revenue of $63.32 million during the quarter, compared to the consensus estimate of $67.93 million. During the same quarter last year, the firm posted $1.08 EPS. The company’s quarterly revenue was up 1.7% on a year-over-year basis. As a group, sell-side analysts predict that National Health Investors will post 4.42 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be paid a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 4.67%. The ex-dividend date is Tuesday, December 31st. National Health Investors’s dividend payout ratio (DPR) is currently 123.71%.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC increased its holdings in National Health Investors by 0.8% during the 3rd quarter. Geode Capital Management LLC now owns 1,094,570 shares of the real estate investment trust’s stock worth $92,026,000 after purchasing an additional 8,540 shares in the last quarter. Vestcor Inc bought a new stake in National Health Investors during the 3rd quarter worth approximately $3,297,000. Barclays PLC increased its holdings in National Health Investors by 323.8% during the 3rd quarter. Barclays PLC now owns 71,703 shares of the real estate investment trust’s stock worth $6,027,000 after purchasing an additional 54,782 shares in the last quarter. Public Employees Retirement System of Ohio increased its holdings in National Health Investors by 0.8% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 62,473 shares of the real estate investment trust’s stock worth $5,251,000 after purchasing an additional 470 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. increased its holdings in National Health Investors by 1.8% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 54,840 shares of the real estate investment trust’s stock worth $4,610,000 after purchasing an additional 990 shares in the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.